PET Scanners Market Trends

Growth Drivers

• Rising Prevalence of Breast Cancer Around the World -according to the World Health Organization, in 2020, breast cancer affected 2.3 million women and caused 685 000 deaths worldwide. By the end of 2020, 7.8 million women were diagnosed with breast cancer. There is a high rate of mortality and morbidity associated with breast cancer in women worldwide. Imaging biomarkers have provided clinically useful information for breast cancer diagnosis and treatment. There have been several studies published and products launched regarding PET-based imaging of breast cancer.
• Developing Guidelines for Radiopharmaceutical Manufacturing- for instance, the International Atomic Energy Agency sanctioned a project in February 2020, offering guidance and technical assistance on manufacturing cyclotron-based gallium-68 radioisotopes and radiopharmaceuticals.
• Increasing Cases of Huntington's Disease Worldwide - it is estimated that approximately 40,000 Americans suffer from Huntington's disease and another 300,000 are at risk for the disease per year. The symptoms usually appear between the ages of 25 and 50. 
• Increased Government Expenditures on Healthcare-according to World Bank data, Global health expenditures increased from 9.7% in 2018 to 9.84% in 2019.
• Growing Geriatric Population Across the Globe - according to the data released by World Bank, the number of geriatric people at the end of 2021 was 747,238,580 worldwide.

Challenges

• Higher Cost Associated With the Positron Emission Tomography Scanners 
• Stringent Set of Regulatory Guidelines For the Product
• Short Life Expectancy of the Scanner